Literature DB >> 7847546

Primary prevention of gynecologic cancers.

D A Grimes1, K E Economy.   

Abstract

A shift from treatment to prevention of the three major gynecologic cancers is overdue. The traditional approach to cervical, endometrial, and ovarian cancers has been secondary or tertiary prevention--early detection and treatment or mitigation of damage, respectively. We reviewed the literature on these cancers to identify strategies for primary prevention. Cervical cancer behaves as a sexually transmitted disease. As with other such diseases, barrier and spermicidal contraceptives lower the risk of cervical cancer; the risk reduction approximates 50%. Combination oral contraceptives help prevent both endometrial and epithelial ovarian cancers. The risk of endometrial cancer among former oral contraceptive users is reduced by about 50% and that of ovarian cancer by about 30% to 60%. Weight control confers strong protection against endometrial cancer. Breast-feeding and tubal sterilization also appear to protect against ovarian cancer. Although women have a range of practical, effective measures available to reduce their risk of these cancers, few are aware of them. Without this information, women cannot make fully informed decisions about their health.

Entities:  

Mesh:

Year:  1995        PMID: 7847546     DOI: 10.1016/0002-9378(95)90125-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Evidence-based case review. Contraception for adolescents.

Authors:  C Davtyan
Journal:  West J Med       Date:  2000-03

2.  Author's response

Authors: 
Journal:  West J Med       Date:  2000-07

Review 3.  Noncontraceptive health benefits of oral contraceptives.

Authors:  Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

4.  Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.

Authors:  Nicolas M Monte; Kaitlyn A Webster; Donna Neuberg; Gregory R Dressler; George L Mutter
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

5.  Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.

Authors:  George L Mutter; Nicolas M Monte; Donna Neuberg; Alex Ferenczy; Charis Eng
Journal:  Cancer Res       Date:  2014-03-24       Impact factor: 12.701

Review 6.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

7.  Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.

Authors:  Tsogzolmaa Dorjgochoo; Xiao-Ou Shu; Hong-Lan Li; Han-Zhu Qian; Gong Yang; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

8.  Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.

Authors:  Ming-Chieh Lin; Kyla A Burkholder; Akila N Viswanathan; Donna Neuberg; George L Mutter
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

9.  From human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control.

Authors:  S M Miller; W Mischel; A O'Leary; M Mills
Journal:  Ann Behav Med       Date:  1996

10.  The use of oral contraceptive before pregnancy and breastfeeding duration: a cross-sectional study with retrospective ascertainment.

Authors:  Nelís Soto-Ramírez; Wilfried Karmaus
Journal:  Int Breastfeed J       Date:  2008-12-16       Impact factor: 3.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.